Our work on understanding how SOCE impacts neuronal percursors now patented by DAE IPR cell. The cells can be used to study the effect of SOCE-modulating drugs on neurodegenerative mechanisms
Happy and excited to share that our paper has been published and now available online!
https://t.co/J6ZE8VZwjz
Our study demonstrates the presence of subtle phenotypes in induced pluripotent stem cells (iPSCs) derived from young-onset Parkinson's disease (PD) patients.
This observation lends credence to the hypothesis that PD is not exclusively a neuronal-autonomous condition. The changes identified may represent potential targets for early intervention in prodromal PD, especially in light of the current absence of disease-modifying therapies.
The department has terrific projects! So apply soon!!
In addition, our lab has recently received Indo-French (Cefipra) and ANRF-ECRG grants. If you are interested in working on RNA evolution and machine learning or single-molecule biophysics of RNA in LLPS, please apply!
As an innovation driven company, we at @EyestemResearch continuously strive to advance the global knowledge base for retinal dystrophies. So glad to see our research getting acknowledged at global conferences. Thx to @CaseyEye@FightBlindness for organizing this amazing event.
Excited to speak at the "9th Retinal Cell and Gene Therapy Innovation Summit" in Seattle, Washington on 3rd May! https://t.co/2SeL21GquQ
The founding team of @EyestemResearch will be at the upcoming @ARVOinfo with a poster on our recently approved Ph 1 study.
@jogin_desai
Bench to bedside in ~7 years! Eyecyte-RPE is a completely indigenously developed product created through a patented and published technology. Thank you everyone who has been a part of this incredible journey!
@jogin_desai@BattuRajani@BIRAC_2012@CCAMP_India